These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30100197)

  • 1. Consumer opinions on adverse events associated with medical devices.
    Aslani P; Hamrosi K; Tong V; Chen TF; Cook J; Fois R; McGarry T; Moore C; Peters R; Spagnardi S; Whitelock K
    Res Social Adm Pharm; 2019 May; 15(5):568-574. PubMed ID: 30100197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consumer opinions on adverse events associated with medicines and vaccines.
    Aslani P; Hamrosi K; Tong V; Chen TF; Cook J; Fois R; McGarry T; Moore C; Peters R; Spagnardi S; Whitelock K
    Patient Prefer Adherence; 2018; 12():1383-1392. PubMed ID: 30104865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AI as a Medical Device Adverse Event Reporting in Regulatory Databases: Protocol for a Systematic Review.
    Kale AU; Dattani R; Tabansi A; Hogg HDJ; Pearson R; Glocker B; Golder S; Waring J; Liu X; Moore DJ; Denniston AK
    JMIR Res Protoc; 2024 Jul; 13():e48156. PubMed ID: 38990628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.
    Aagaard L; Hallgreen CE; Hansen EH
    Int J Obes (Lond); 2016 Nov; 40(11):1742-1747. PubMed ID: 27478924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumers' perspectives on their involvement in recognizing and responding to patient deterioration-Developing a model for consumer reporting.
    King L; Peacock G; Crotty M; Clark R
    Health Expect; 2019 Jun; 22(3):385-395. PubMed ID: 30588720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of adverse events for a home-use intense pulsed light hair removal device using postmarketing surveillance.
    Hattersley AM; Kiernan M; Goldberg D; Dierickx C; Sliney DH; Haedersdal M; Nash JF
    Lasers Surg Med; 2023 Apr; 55(4):414-422. PubMed ID: 36883997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do consumers search for and appraise information on medicines on the Internet? A qualitative study using focus groups.
    Peterson G; Aslani P; Williams KA
    J Med Internet Res; 2003 Dec; 5(4):e33. PubMed ID: 14713661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical device report analyses from MAUDE: Device and patient outcomes, adverse events, and sex-based differential effects.
    Liao TJ; Crosby L; Cross K; Chen M; Elespuru R
    Regul Toxicol Pharmacol; 2024 May; 149():105591. PubMed ID: 38467236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that influence the recognition, reporting and resolution of incidents related to medical devices and other healthcare technologies: a systematic review.
    Polisena J; Gagliardi A; Urbach D; Clifford T; Fiander M
    Syst Rev; 2015 Mar; 4():37. PubMed ID: 25875375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug and device reactions in the oral cavity: surveillance and reporting.
    Zavras AI; Rosenberg GE; Danielson JD; Cartsos VM
    J Am Dent Assoc; 2013 Sep; 144(9):1014-21. PubMed ID: 23989840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the reporting of adverse medical device events: qualitative interviews with physicians about higher risk implantable devices.
    Gagliardi AR; Ducey A; Lehoux P; Turgeon T; Ross S; Trbovich P; Easty A; Bell C; Urbach D
    BMJ Qual Saf; 2018 Mar; 27(3):190-198. PubMed ID: 28768712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting of Cardiovascular Medical Device Adverse Events to Pharmaceuticals and Medical Devices Agency, Japan.
    Handa N; Ishii K; Matsui Y; Ando Y
    EBioMedicine; 2015 Sep; 2(9):1211-6. PubMed ID: 26501120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of medical device-related hazards and adverse events in hospitalized patients.
    Samore MH; Evans RS; Lassen A; Gould P; Lloyd J; Gardner RM; Abouzelof R; Taylor C; Woodbury DA; Willy M; Bright RA
    JAMA; 2004 Jan; 291(3):325-34. PubMed ID: 14734595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving patient care by reporting problems with medical devices.
    White GG; Weick-Brady MD; Goldman SA; Gross TP; Kennedy DL; Lucas BS; Merritt K; Naschinski C
    CRNA; 1998 Nov; 9(4):139-56. PubMed ID: 9866489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
    Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
    Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical device regulation in Australia: safe and effective?
    McGee RG; Webster AC; Rogerson TE; Craig JC
    Med J Aust; 2012 Mar; 196(4):256-60. PubMed ID: 22409692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post market surveillance in the german medical device sector - current state and future perspectives.
    Zippel C; Bohnet-Joschko S
    Health Policy; 2017 Aug; 121(8):880-886. PubMed ID: 28697849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of adverse event reporting for medical devices, India.
    Shukla S; Gupta M; Pandit S; Thomson M; Shivhare A; Kalaiselvan V; Singh GN
    Bull World Health Organ; 2020 Mar; 98(3):206-211. PubMed ID: 32132755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.